Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pharmazie ; 56(4): 306-10, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11338669

RESUMO

The analysis of several impurities of the chemotherapeutic agent trimethoprim with various methods, including thin layer chromatography, gas chromatography, capillary electrophoresis as well as nuclear magnetic resonance is described. These methods were used to identify new impurities in trimethoprim batches. The main impurities were separated by column chromatography. To ensure the identity of the impurities, de novo syntheses were successfully carried out. With the methods described, it was possible to detect, separate and identify new impurities in trimethoprim batches.


Assuntos
Anti-Infecciosos Urinários/química , Contaminação de Medicamentos , Trimetoprima/química , Cromatografia Líquida de Alta Pressão , Cromatografia em Camada Fina , Eletroquímica , Eletroforese Capilar , Cromatografia Gasosa-Espectrometria de Massas , Indicadores e Reagentes , Espectroscopia de Ressonância Magnética
2.
Yeast ; 16(14): 1273-85, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11015725

RESUMO

Phosphofructokinase-1 (Pfk-1) from Schizosaccharomyces pombe was purified by 54-fold enrichment to homogeneity elaborating the following steps: (a) Disruption of the cells with glass beads; (b) fractionated precipitation with polyethylene glycol 6000; (c) affinity chromatography on Cibacron-Blue F3G-A-Sephadex G 100; (d) ion exchange chromatography on Resource Q. The native enzyme exhibits a mass of 790+/-30 kDa, as detected by sedimentation equilibrium measurements. The apparent sedimentation coefficient was found to be s(20,c)=20.2+/-0.3 S. No significant dependence of the s-value on the protein concentration was observed in the range 0. 07-0.7 mg/ml. Polyacrylamide gel electrophoresis in presence of sodium dodecyl sulphate and MALDI-TOF spectra showed that the enzyme is composed of subunits of identical size of 100+/-5 kDa, forming an octameric structure. The N-terminus of the enzyme was found to be blocked. Sequences of tryptic and chymotryptic peptides of the subunit coincide with the proposed amino acid sequence as deduced from the gene from the EMBL library. The Pfk-1 coding sequence of S. pombe was transformed into a Pfk-1 double deletion mutants of Saccharomyces cerevisiae resulting in glucose-positive cells with enzyme activity in the crude cell extract. The kinetic analysis revealed less cooperativity to fructose 6-phosphate (n(H)=1.6) and less inhibition by ATP as compared to the enzyme from baker's yeast. Fructose 2,6-bisphosphate (in micromolar range) and AMP (in millimolar range) were found to overcome ATP inhibition and to increase the affinity to fructose 6-phosphate.


Assuntos
Fosfofrutoquinase-1/química , Fosfofrutoquinase-1/isolamento & purificação , Subunidades Proteicas , Schizosaccharomyces/enzimologia , Monofosfato de Adenosina/farmacologia , Trifosfato de Adenosina/farmacologia , Sequência de Aminoácidos , Centrifugação com Gradiente de Concentração , Eletroforese em Gel de Poliacrilamida , Frutosefosfatos/metabolismo , Concentração de Íons de Hidrogênio , Cinética , Dados de Sequência Molecular , Peso Molecular , Fosfofrutoquinase-1/antagonistas & inibidores , Fosfofrutoquinase-1/metabolismo , Alinhamento de Sequência , Análise de Sequência de Proteína , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz
3.
Biochemistry ; 39(35): 10761-9, 2000 Sep 05.
Artigo em Inglês | MEDLINE | ID: mdl-10978161

RESUMO

A still unknown low-molecular-mass cofactor essential for the activity of carnitine-metabolizing enzymes (e.g., L-carnitine dehydratase, crotonobetaine reductase) from E. coli has been purified to homogeneity from a cell-free extract of E. coli O44K74. The purity of the cofactor was confirmed by HPLC analysis. Biosynthesis of the unknown compound was only observed when bacteria were cultivated anaerobically in the presence of L-carnitine or crotonobetaine. The determined properties, together with results obtained from UV-visible, (1)H NMR, and mass spectrometry, indicate that the compound in question is a new CoA derivative. The esterified compound was suggested to be gamma-butyrobetaine-a metabolite of carnitine metabolism of E. coli. Proof of structure was performed by chemical synthesis. Besides gamma-butyrobetainyl-CoA, a second new CoA derivative, crotonobetainyl-CoA, was also chemically synthesized. Both CoA derivatives were purified and their structures confirmed using NMR and mass spectrometry. Comparisons of structural data and of the chemical properties of gamma-butyrobetainyl-CoA, crotonobetainyl-CoA, and the isolated cofactor verified that the unknown compound is gamma-butyrobetainyl-CoA. The physical and chemical properties of gamma-butyrobetainyl-CoA and crotonobetainyl-CoA are similar to known CoA derivatives.


Assuntos
Acil Coenzima A/isolamento & purificação , Aciltransferases , Betaína/análogos & derivados , Betaína/metabolismo , Carnitina/metabolismo , Escherichia coli/enzimologia , Acil Coenzima A/biossíntese , Acil Coenzima A/química , Betaína/química , Fenômenos Químicos , Físico-Química , Cromatografia Líquida de Alta Pressão , Hidroliases/metabolismo , Espectrometria de Massas , Peso Molecular , Ressonância Magnética Nuclear Biomolecular , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Espectrofotometria Ultravioleta
4.
Rapid Commun Mass Spectrom ; 14(14): 1307-8, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10918385

RESUMO

Electrospray mass spectrometry is a standard tool for the investigation of biological samples. Due to the high flowrates of the standard sources, large sample amounts are required and it is almost impossible to spray physiological solutions due to their aqueous medium. The introduction of microelectrospray sources has made it possible to decrease the sample amounts needed and enabled the use of buffered solutions. In this work, a nanoES-like source based on a modification of an existing IonSpray source is introduced. In contrast to other nanoES sources available, the modification presented allows a fast change between the nanoES and the normal IonSpray modes. Copyright 2000 John Wiley & Sons, Ltd.

5.
Mikrobiologiia ; 53(3): 423-6, 1984.
Artigo em Russo | MEDLINE | ID: mdl-6748972

RESUMO

The ability to emulsify n-hexadecane was compared among ten strains of Candida lipolytica. The cultures were shown to differ in the activity of emulsification. The highest activity was recorded in the phase of growth deceleration. Substances involved in n-alkane emulsification were isolated.


Assuntos
Alcanos/metabolismo , Candida/metabolismo , Candida/crescimento & desenvolvimento , Meios de Cultura/metabolismo , Emulsões , Excipientes/isolamento & purificação , Fatores de Tempo
8.
Acta Biol Med Ger ; 36(9): 1237-42, 1977.
Artigo em Alemão | MEDLINE | ID: mdl-614747

RESUMO

The uptake of acetate by intact nongrowing cells of Acinetobacter calcoaceticus was studied in dependence on the C-source (acetate, n-alcanes, yeast extract, succinate, L-malate) and the growth phase. Single kinetic parameters of acetate uptake were determined. The best acetate uptake was observed with cells cultivated with acetate as the only C-source. Bacteria in the early growth phase were found to transfer acetate twice as fast as cells of the late logarithmic growth phase. The uptake of acetate can be described by a biphasic saturation kinetics with 2 Km values: the Km value for the first phase being 1.10(-5) M, and for the second one, 1.8 .10(-4) M. The corresponding maximal uptake rates are 8 and 37 mM/min/mg dry weight, respectively. Alpha-ketoglutarate, fumarate, L-malate, and oxalacetate inhibit the initial uptake of acetate. Uranylacetate, inhibitors of the respiratory chain and proton conductors in part completely inhibit the uptake of acetate.


Assuntos
Acetatos/metabolismo , Acinetobacter/metabolismo , Acinetobacter/crescimento & desenvolvimento , Depressão Química , Fumaratos/farmacologia , Ácidos Cetoglutáricos/farmacologia , Cinética , Malatos/farmacologia , Oxaloacetatos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...